VALIDATION OF NONALCOHOLIC FATTY LIVER DISEASE ( NAFLD) OUTCOME SCORE ( NOS) TO PREDICT LIVER- RELATED EVENTS IN NAFLD: AN INTERNATIONAL MULTICENTER STUDY

被引：0

作者：

Tay, Wei Xuan ^{[1
]}

Chan, Yiong Huak ^{[2
]}

Aboona, Majd ^{[3
]}

Song, Michael W. ^{[4
]}

Faulkner, Claire ^{[3
]}

Han, Nicole Xinrong ^{[5
]}

Cristiu, Jessica ^{[6
]}

Wijarnpreecha, Karn ^{[7
]}

Chen, Vincent ^{[8
]}

Wong, Yu Jun ^{[1
]}

机构：

[1] Changi Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore

[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore

[3] Univ Arizona, Coll Med, Phoenix, AZ USA

[4] Univ Michigan, Ann Arbor, MI USA

[5] Changi Gen Hosp, Singapore, Singapore

[6] Univ Michigan, Ann Arbor, MI USA

[7] Univ Arizona, Coll Med Phoenix, Phoenix, AZ USA

[8] Univ Michigan, Med Ctr, Ann Arbor, MI USA

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2128- A

引用

页码：S904 / S905

页数：2

共 50 条

[21] Risk of Nonalcoholic Fatty Liver Disease (NAFLD)-Related Liver Complications in the Diabetic Population in Israel
Goldshtein, Inbal
Fernandes, Gail
Chodick, Gabriel
Rajpathak, Swapnil
Karasik, Avraham
DIABETES, 2018, 67
[22] Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
Duarte, Sebastiao M. B.
Stefano, Jose Tadeu
Oliveira, Claudia P.
ANNALS OF HEPATOLOGY, 2019, 18 (03) : 416 - 421
[23] DIAGNOSING NONALCOHOLIC STEATOHEPATITIS (NASH) AMONG PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD): FEQUENCY AND PREDICTORS OF NAFLD ACTIVITY SCORE MEASUREMENT
Katz, J.
Heinz, S.
DiBonaventura, M.
VALUE IN HEALTH, 2017, 20 (05) : A180 - A180
[24] Derivation and validation of a model that differentiates alcoholic liver disease (ALD) from nonalcoholic fatty liver disease (NAFLD)
Dunn, Winston
Angulo-Hernandez, Paul
Sanderson, Schuyler
Malinchoc, Michael
Rosen, Charles
Stadheim, Linda
Shah, Vijay
GASTROENTEROLOGY, 2006, 130 (04) : A767 - A767
[25] CHARACTERISTICS OF THE FATTY ACID COMPOSITION IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Yamada, K.
Mizukoshi, E.
Takeshita, Y.
Arai, K.
Yamashita, T.
Sakai, A.
Kaneko, S.
JOURNAL OF HEPATOLOGY, 2011, 54 : S505 - S506
[26] Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD)
Xin, Xin
Chen, Cheng
Hu, Yi-Yang
Feng, Qin
BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
[27] Nonalcoholic fatty liver disease (NAFLD): Approach in the adolescent patient
Roberts E.A.
Yap J.
Current Treatment Options in Gastroenterology, 2006, 9 (5) : 423 - 431
[28] Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
Kaswala, Dharmesh H.
Lai, Michelle
Afdhal, Nezam H.
DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (05) : 1356 - 1364
[29] Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)
Ajay Duseja
Naga Chalasani
Hepatology International, 2013, 7 : 755 - 764
[30] THE NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) CONUNDRUM: HOW TO DEFINE IT?
Mato, J. M.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 5 - 5

← 1 2 3 4 5 →